ArticleMedical oncology (Northwood, London, England)2023

CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancer.

Wenqiang Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.